Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001722561 | SCV000714474 | likely benign | not provided | 2019-03-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000860598 | SCV001000700 | benign | Long QT syndrome | 2024-11-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253520 | SCV002525070 | benign | Cardiac arrhythmia, ankyrin-B-related | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002420588 | SCV002676485 | likely benign | Cardiovascular phenotype | 2017-12-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002253520 | SCV002802329 | likely benign | Cardiac arrhythmia, ankyrin-B-related | 2021-08-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003155247 | SCV003844622 | benign | not specified | 2023-02-13 | criteria provided, single submitter | clinical testing |